SCHEMBL9264166

SCHEMBL9264166

Oc1ccc(SC2CCCCC2O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.49
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
TSHR P16473 2/20 0.42
NR1H2 P55055 1/20 0.38
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ESR2 Q92731 2/20 0.34
KMT2A Q03164 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
MIF P14174 2/20 0.32
EPHX1 P07099 1/20 0.31
CTSK P43235 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
CA12 O43570 1/20 0.31
GMNN O75496 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9264159 1.00 HTT (0.49) HTTNPC1RAB9ATSHRNR1H2
SCHEMBL9264162 1.00 HTT (0.49) HTTNPC1RAB9ATSHRNR1H2
SCHEMBL9265403 0.83 HTT (0.47) HTTNPC1RAB9ATSHRALDH1A1
SCHEMBL9261011 0.83 HTT (0.47) HTTNPC1RAB9ATSHRALDH1A1
SCHEMBL9261015 0.83 HTT (0.47) HTTNPC1RAB9ATSHRALDH1A1
SCHEMBL9261017 0.83 HTT (0.47) HTTNPC1RAB9ATSHRALDH1A1
SCHEMBL9264878 0.83 HTT (0.56) HTTNPC1RAB9ATSHRALDH1A1
SCHEMBL1496659 0.83 HTT (0.47) HTTNPC1RAB9ATSHRALDH1A1
SCHEMBL9263462 0.83 HTT (0.47) HTTNPC1RAB9ATSHRALDH1A1
SCHEMBL9263459 0.83 HTT (0.47) HTTNPC1RAB9ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5476944-A Inhibitors or stimulators of superoxide generation; may also inhibit cyclooxygenase and/or 5-lipoxygenase; useful in therapeutic or prophylactic treatment of disease conditions G. D. SEARLE & CO. (US) 1995-12-19 US disclosed
EP-0613463-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1994-09-07 EP disclosed
WO-1993010087-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1993-05-27 WO disclosed